Kavanaugh CJ - Search Results

1

Pre-clinical applications of transgenic mouse mammary cancer models.

Kavanaugh CJ, Desai KV, Calvo A, Brown PH, Couldrey C, Lubet R, Green JE. Kavanaugh CJ, et al. Transgenic Res. 2002 Dec;11(6):617-33. doi: 10.1023/a:1021159705363. Transgenic Res. 2002. PMID: 12509137 Review.

2

The use of genetically altered mice for breast cancer prevention studies.

Kavanaugh C, Green JE. Kavanaugh C, et al. J Nutr. 2003 Jul;133(7 Suppl):2404S-2409S. doi: 10.1093/jn/133.7.2404S. J Nutr. 2003. PMID: 12840216 Review.

3

Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy.

Green JE, Desai K, Ye Y, Kavanaugh C, Calvo A, Huh JI. Green JE, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):385S-90S. doi: 10.1158/1078-0432.ccr-031201. Clin Cancer Res. 2004. PMID: 14734496

4

Application of gene expression profiling for validating models of human breast cancer.

Green JE, Desai KV, Ye Y, Kavanaugh C, Calvo A, Huh JI. Green JE, et al. Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:84-9. doi: 10.1080/01926230490424897. Toxicol Pathol. 2004. PMID: 15209407 Review.

5

Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.

Desai KV, Kavanaugh CJ, Calvo A, Green JE. Desai KV, et al. Among authors: kavanaugh cj. Endocr Relat Cancer. 2002 Dec;9(4):207-20. doi: 10.1677/erc.0.0090207. Endocr Relat Cancer. 2002. PMID: 12542399 Review.

6

Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling.

Ye Y, Qiu TH, Kavanaugh C, Green JE. Ye Y, et al. Breast Dis. 2004;19:69-82. doi: 10.3233/bd-2004-19109. Breast Dis. 2004. PMID: 15687699

7

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.

Shibata MA, Kavanaugh C, Shibata E, Abe H, Nguyen P, Otsuki Y, Trepel JB, Green JE. Shibata MA, et al. Carcinogenesis. 2003 Mar;24(3):453-9. doi: 10.1093/carcin/24.3.453. Carcinogenesis. 2003. PMID: 12663504

8

Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE. Deeb KK, et al. Cancer Res. 2007 Sep 1;67(17):8065-80. doi: 10.1158/0008-5472.CAN-07-1515. Cancer Res. 2007. PMID: 17804718

9

4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.

Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ, Grubbs CJ. Lubet RA, et al. Among authors: kavanaugh c. Carcinogenesis. 2005 Mar;26(3):571-8. doi: 10.1093/carcin/bgh352. Epub 2004 Dec 9. Carcinogenesis. 2005. PMID: 15591090

10

Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review.

Kavanaugh CJ, Trumbo PR, Ellwood KC. Kavanaugh CJ, et al. Nutr Cancer. 2009;61(2):157-64. doi: 10.1080/01635580802395741. Nutr Cancer. 2009. PMID: 19235032 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters